Hikma Recalls Irinotecan Hydrochloride Injection Due to Container Defect
Hikma Pharmaceuticals is recalling 82,426 vials of Irinotecan Hydrochloride Injection due to a crimp defect in the flip-cap.
- Product
- IRINOTECAN HYDROCHLORIDE — IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide